- National Health Service (NHS) England views shared decision-making as a vital part of providing good care, describing it as “a process in which clinicians and individuals work together to select tests, treatments, management, or support packages, based on evidence and the individual’s informed preferences.”1 It also states the need for “evidence-based decision support tools that are tailored to support people (especially those with low levels of health literacy) to understand their options and what is known of the benefits, harms, consequences, and burdens of those options.”
- The tools of digital health are facilitating a much-needed paradigm shift to a more patient-centric health care delivery system, yet our health care infrastructure is firmly rooted in a 20th-century model that was not designed to receive medical data from outside the traditional medical environment. COVID-19 has accelerated this adoption and illustrated the challenges that lie ahead as we make this shift. The diverse ecosystem of digital health tools share 1 feature in common: they generate data that must be processed, triaged, acted upon, and incorporated into the longitudinal electronic health record.
- Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), started in the city of Wuhan in late 2019. Within a few months, the disease spread toward all parts of the world and was declared a pandemic on March 11, 2020. The current health care dilemma worldwide is how to sustain the capacity for quality services not only for those suffering from COVID-19 but also for non-COVID-19 patients, all while protecting physicians, nurses, and other allied health care workers.
- The pandemic caused by novel coronavirus (SARS-CoV-2) has had an enormous impact on the health and economy of the entire world.1 The total numbers of cases and fatalities continue to rise and the mortality rate is currently estimated to be 1%–5%.2 Of the multiple symptoms and clinical findings that have been attributed to COVID-19 infection, fever and cough are the most common,3 and significance in terms of widespread screening has been defined as temperatures ≥100.5°F/38°C.4 Cardiac injury and cardiac mortality have also become part of the emerging clinical picture of COVID-19,4–6 and this raises the prospect of how to use implantable devices such as implantable cardiac monitors (ICMs) to aid in the screening or triage of suspected patients.